il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

More documents

Recommendations

Info

Ong,D.E. and F.Chyt tl. lg7 5. "Retinoic acid-binding protein in rat tissue' Partial purification and comparison to rat tissue retinol-binding protein." J'Biol'chem' 2506113-6117. Orrenius,S., D.J.McCoú"y, G.Bellomo, and P.Nicotera. 1989' "Role of CaZ+ in toxic cell killing ." Trends P harmacol'Sci' 10'281 -285' ou,H., J.Haendeler, M.R.Aebly, L.A.Kelly, B.C.Cholewa, G.Koike, A.Kwitek-B1ack, H.J.Jacob,B'C.Berk,andJ.M.Miano.2000.''Retinoicacid-inducedtissue transglutaminase and apoptosis in vascular smooth muscle cells'" Circ'Res' 87:881-887. Oyama,J., S.Frantz, J.C.Blais, Jr., R.A.Kelly, and T.Bourcier.2002. "Nitric oxide, cell death, and heart failure." Heart Fail'Rev 7:327-334' Palace,V.P., N.Khaper, Q.Qin, and P.K.Singal.1999. "Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease." Free Radic'Biol.Med' 26:746-761. Papassotiropoulos,A., M.Ludwig, v/.Naib-Majani, and G.s.Rao. 1996. "Induction of apoptosis and secondary necrosis in rat dorsal root ganglion cell cultures by oxidized low density lipoprotein ." Neur os ci. Lett. 209 :33 -36. Paranka,N.S. and R.T.Don. 1994. "Effect of doxorubicin on glutathione and glutathionedependent enzymes in cultured rat heart cells." Anticancer Res. 14:2047-2052' Parker,T.G. 1995. "Moiecular biology of myocardial hypertrophy and failure: gene expressionandtrophicsignaling'''NewHoriz.3:288-300. Pearce,L.L., M.W.Epperly, J'S.Greenberger, B'R'Pitt, and J'Peterson' 2001' ,,Identification of respiratory complexes I and III as mitochondrial sites of damage following exposure to ionizing radiation and nitric oxide." Nitric.Oxide' 5:128- 136. 160
petkovich,M., N.J.Brand, A.Krust, and P.chambon. 1987. "A human retinoic acid receptor which belongs to the family of nuclear receptors." Nature.330:444-450' pij nappel,w.w., H.F.Hendriks, G. E.Folkers, c.E.van den Brink, E. J.Dekker, c.Edelenbosch, P.T.van der saag, and A.J.Durston. 1993. "The retinoid ligand 4- oxo-retinoic acid is a highly active modulator of positional specification'" Nature' 366.340-344. piper,H.M., S.L.Jacobson, and P.Schwartz. Determinants of cardiomyocyte development in long-term primary culture. J.Mol.Cell Cardiol. 20,825-835. 1988. Ref Type: Abstract Ponzoni,M., P.Bocca, V.Chiesa, A.Decensi, V.Pistoia, L'Raffaghello, C.Rozzo, and p.G.Montaldo. 1995. "Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation." Cancer R¿s.55:853-861. porter,A.G., p.Ng, and R.U.Janicke.1997. "Death substrates come alive." Bioessays' 19:501-507. praga,c., G.Beretta, P.L.Vigo, G.R.Lenaz, C.Pollini, G.Bonadonna, R.canetta, R.Castellani, E.Viila, C.G.Gallagher, H.von Melchner, M'Hayat, P'Ribaud, G'De wasch,'w.Mattsson, R.Heinz, R.waldner, K.Kolaric, R.Buehner, w.Ten Bokkel- Huyninck, N.I.Perevodchikova, L. A.Manziuk, H. J. s enn, and A. c'M ayt. 197 9' "Adriamycin cardiotoxicity: a survey of 1273 patients." Cancer Treat'Rep. 63:827-834 prasad,K. and J.Kalra.Igg3. "Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin 8." Am.Heart J. 125:958-973. Quigley,G.J., A.H.Wang, G.Ughetto, G.van der Marel, J.H.van Boom, and A.Rich. 1980. "Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG). " P r o c. N atl' Acad. S ci' U' S' A' 7 7 :7 20 4'7 208' 161
Page 1 and 2:
il\VOLVEMENT OF RETII\OIC ACID II{
Page 3 and 4:
Title: AKNOWLEDGMENTS DEDICATION LI
Page 5 and 6:
IV.b.3. The uptake to peripheral ti
Page 7 and 8:
II.a. Total RAR and total RXR recep
Page 9 and 10:
ACKNO\ryLEDGMENTS I must say that m
Page 11 and 12:
DEDICATION To my toughest critic, m
Page 13 and 14:
Figure: LIST OF FIGURES Page: 1. Ch
Page 15 and 16:
30. A and B The expression of anti-
Page 17 and 18:
treated (ADR), trolox treated (TROL
Page 19 and 20:
INTRODUCTION Adriamycin, an anthrac
Page 21 and 22:
apoptosis, which will ultimately pr
Page 23 and 24:
LITERATURE REVIE\il I. Adriamycin i
Page 25 and 26:
Binding and alkylation of DNA Inter
Page 27 and 28:
myocardial inflammation which was s
Page 29 and 30:
1990; Kusuoka et al. l99l; Olson et
Page 31 and 32:
levels of antioxidant enzymes (Odom
Page 33 and 34:
causing the increased leakage of el
Page 35 and 36:
mechanisms which are involved in th
Page 37 and 38:
to protect against adriamycin-induc
Page 39 and 40:
The usage of Probucol.' Most promis
Page 41 and 42:
II. Oxidative stress II.a. Introduc
Page 43 and 44:
of a large array of cellular abnorm
Page 45 and 46:
menstruation (Kokawa et al. 1996),
Page 47 and 48:
DNA(Cohen 1997; Saikumar et al. 199
Page 49 and 50:
pathogenesis of heart failure. A nu
Page 51 and 52:
elonging to spontaneous hlpertensiv
Page 53 and 54:
AlþTrsns Retlnolc Acld fAfRAl g€
Page 55 and 56:
dehydrogenase (SDR), alcohol dehydr
Page 57 and 58:
(Bavik et a|. 1991). Soon after its
Page 59 and 60:
et al. 1994; Napoli 1996). The func
Page 61:
is achieved through its binding to
Page 64 and 65:
Retinoic acid signaling pathwaybegi
Page 66 and 67:
(Bavik et al. 1997). One of the mos
Page 68 and 69:
cells (Gaetano et ai. ZOot¡. The s
Page 70 and 71:
neuroblastoma, genn cell tumors and
Page 72 and 73:
presence of two distinctive pathway
Page 74 and 75:
cytochrome C release from mitochond
Page 76 and 77:
peroxidation (Sultana et a|.2004).
Page 78 and 79:
adipose tissue and to a lesser exte
Page 80 and 81:
such as; increased generation of re
Page 82 and 83:
physiological and pathological proc
Page 84 and 85:
Protective effects of PPAR y agonis
Page 86 and 87:
IIYPOTHESIS This study tests the hy
Page 88 and 89:
I.c.Collection of Tissues Hearts we
Page 90 and 91:
thoracotomy was performed and heart
Page 92 and 93:
Il.c.Western Blot Analvsis Western
Page 94 and 95:
green were counted as dead cells. T
Page 96 and 97:
RESULTS I.In Vivo Studies I.a.Gener
Page 101:
Lc. Retinoic acid receptors Three w
Page 108:
The RAR o and PPAR-õ receptors RNA
Page 113 and 114:
significantly decreased when compar
Page 116:
IL b.7. RAR alPha recePtor levels T
Page 120:
ILb. 3. RAR sammø recEtor levels F
Page 124:
ILb. 5. RXR baa recEúor levels The
Page 129: visible staining were accounted as
Page 137 and 138: DISSCUSION I. Adriamvcin CardiomvoP
Page 139 and 140: Treatment with adriamycin has been
Page 141 and 142: High RA 1 Adriamycin I oxidative st
Page 143 and 144: study as well as in others (Kumar e
Page 145 and 146: It is reported that PPAR y receptor
Page 147 and 148: expression. These effects of trolox
Page 149 and 150: REFERENCES Abdul Hamied,T.A., D.Par
Page 151 and 152: Bashor,M.M., D.O.Toft, and F.Chytll
Page 153 and 154: distribution of PPAR-alpha, -beta,
Page 155 and 156: colbert,M.C., D.G.Hall, T.R.Kimball
Page 157 and 158: Diep,Q.N., M'El Mabrouk, J.S.Cohn,
Page 159 and 160: Evans,R.M. 1988. "The steroid and t
Page 161 and 162: Ghione M. Development of Adriamycin
Page 163 and 164: Herman,E., R.Young, and S.Krop . Ig
Page 165 and 166: morphogenetic protein-2 inhibits se
Page 167 and 168: Khandoudi,N., P.Delerive, I.Berrebi
Page 169 and 170: Kusuoka,H., S.Futaki, Y.Koretsune,
Page 171 and 172: and myosin heavy chain gene express
Page 173 and 174: Mehta,J.L., B.Hu, J.Chen, and D.Li.
Page 175 and 176: Morriss-Kay,G.M. and s.J.ward. 1999
Page 177: Notario,B., M.Zamora, O.Vinas, and
Page 181 and 182: Ruberte,E., P.Dolle, P.Chambon, and
Page 183 and 184: Sharov,V.G., H.N.Sabbah, H.Shimoyam
Page 185 and 186: spiegelman,B.M. and J.s.Flier .1996
Page 187 and 188: Teebor,G.w., R.J.Boorstein, and J.c
Page 189 and 190: vanVeen,T.A.,H.V.vanRijen,R.F.V/ieg
Page 191 and 192: wi1liams,J.B. and J.L.Napoli. 1985.
Page 193 and 194: peroxisome proliferator-activated r
show all

il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?